StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
PHGE

BiomX Inc.

PHGE NYSE Biological Products, (No Diagnostic Substances) EDGAR ↗
$0.19
-0.00 -1.16%

Key statistics

from XBRL data in SEC filings
Market cap
$1.90M
Revenue (TTM)
Net income (TTM)
-$47.7M
EPS (TTM)
$23.30
P/E ratio
0.0
Dividend yield
Free cash flow
-$26.4M
Cash
$1.17M
Total assets
$3.25M
Gross margin
52-week range
$0.17 – $13.70

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Entered a material agreement; Unregistered sale of equity Jul 28, 2026 8-K Other events Jul 10, 2026 8-K Changed accountants Jul 2, 2026 8-K Shareholder vote results Jun 26, 2026 8-K Regulation FD disclosure Jun 18, 2026 8-K Delisting notice or listing-rule failure; Regulation FD disclosure Jun 12, 2026 8-K/A AMENDMENT NO. 1 TO FORM 8-K Jun 12, 2026 8-K Unregistered sale of equity Jun 5, 2026 8-K Director or officer change May 28, 2026 10-Q Quarter ended 2026-03-31 May 20, 2026 8-K Other events May 5, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 8-K Regulation FD disclosure; Other events Apr 16, 2026 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Regulation FD disclosure Apr 13, 2026 8-K Shareholder vote results Apr 10, 2026 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Regulation FD disclosure Apr 10, 2026 8-K Entered a material agreement Apr 1, 2026 8-K Delisting notice or listing-rule failure; Other events Mar 27, 2026 8-K Entered a material agreement; Regulation FD disclosure Mar 19, 2026 8-K Shareholder vote results Mar 11, 2026 8-K Director or officer change Mar 6, 2026 8-K Director or officer change; Other events Mar 2, 2026 8-K Director or officer change Feb 25, 2026 10-K Fiscal year ended 2025-12-31 Feb 19, 2026 8-K Director or officer change Feb 13, 2026 8-K Completed an acquisition or disposition; Director or officer change Feb 10, 2026 8-K Modified rights of security holders; Director or officer change; Amended charter or bylaws Jan 14, 2026 8-K Terminated a material agreement Jan 7, 2026 8-K Entered a material agreement; Unregistered sale of equity Dec 29, 2025 8-K Other events Dec 11, 2025 8-K Other events Dec 8, 2025 8-K Other events Nov 25, 2025 8-K Modified rights of security holders; Amended charter or bylaws Nov 17, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Shareholder vote results Oct 17, 2025 8-K Other events Oct 17, 2025 8-K Other events Aug 19, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Results of operations (earnings release) Aug 13, 2025